Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Aileen M. Cleary is active.

Publication


Featured researches published by Aileen M. Cleary.


Molecular Immunology | 1991

A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4

Seth Lederman; Julie A. DeMartino; Bruce L. Daugherty; Ivan Foeldvari; Michael J. Yellin; Aileen M. Cleary; Noah Berkowitz; Israel Lowy; Ned S. Braunstein; George E. Mark; Leonard Chess

The CD4 molecule is a relatively non-polymorphic 55 kDa glycoprotein expressed on a subset of T lymphocytes. A common African allele of CD4 has been identified by non-reactivity with the monoclonal antibody, OKT4. The genetic basis for the OKT4- polymorphism of CD4 is unknown. In the present paper, the structure of the CD4 molecule from an homozygous CD4OKT4- individual was characterized at the molecular level. The size of the CD4OKT4- protein and mRNA were indistinguishable from those of the OKT4+ allele. The polymerase chain reaction (PCR) was used to map the structure of CD4OKT4- cDNAs by amplifying overlapping DNA segments and to obtain partial nucleotide sequence after asymmetric amplification. PCR was then used to clone CD4OKT4- cDNAs spanning the coding region of the entire, mature CD4 protein by amplification of two overlapping segments followed by PCR recombination. The nucleotide sequence of CD4OKT4- cDNA clones revealed a G----A transition at bp 867 encoding an arginine----tryptophan substitution at amino acid 240 relative to CD4OKT4+. Expression of a CD4OKT4- cDNA containing only this transition, confirmed that the arginine----tryptophan substitution at amino acid 240 ablates the binding of the mAb OKT4. A positively charged amino acid residue at this position is found in chimpanzee, rhesus macaque, mouse and rat CD4 suggesting that this mutation may confer unique functional properties to the CD4OKT4- protein.


Current Opinion in Hematology | 1996

The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes.

Seth Lederman; Aileen M. Cleary; Michael J. Yellin; Dale Frank; Michael Karpusas; David W. Thomas; Leonard Chess

This review summarizes recent findings concerning the role of CD40‐ligand and CD40 interactions in B‐cell differentiation. CD40‐ligand on helper CD4+ T lymphocytes interacts with CD40 on B cells and directs the selection and differentiation of clones of B lymphocytes to generate specific antibodydependent immune responses. CD40‐ligand is necessary for normal B‐cell differentiation and plays several distinctive roles in this multistage process. The CD40 signaling pathway that normally regulates B‐cell death appears to be usurped by the Epstein‐Barr virus to mediate B‐cell transformation.


Current Opinion in Immunology | 1993

Non-antigen signals for B-cell growth and differentiation to antibody secretion.

Seth Lederman; Michael J. Yellin; Lori R. Covey; Aileen M. Cleary; Robin Callard; Leonard Chess

Recently, significant progress had been made in understanding the T-B lymphocyte interactions that control humoral immunity. This review highlights experiments that demonstrate a central role for interactions between T-cell-B-cell-activating molecule (CD40 ligand) expressed on T cells and CD40 on B cells in B-cell activation and immunoglobulin isotype switching, both in vitro and in vivo.


Journal of Immunology | 1994

T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.

Seth Lederman; Michael J. Yellin; Aileen M. Cleary; Alessandra B. Pernis; Giorgio Inghirami; Lauren E. Cohn; Lori R. Covey; J J Lee; Paul Rothman; Leonard Chess


Journal of Immunology | 1995

Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.

Aileen M. Cleary; Sarah M. Fortune; Michael J. Yellin; Leonard Chess; Seth Lederman


Antisense research and development | 1993

Phosphorothioate Oligodeoxynucleotides Bind to the Third Variable Loop Domain (v3) of Human Immunodeficiency Virus Type 1 gp120

C.A. Stein; Aileen M. Cleary; Leonid Yakubov; Seth Lederman


Molecular Immunology | 1994

Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells : identity with the CD40-ligand

Lori R. Covey; Aileen M. Cleary; Michael J. Yellin; Randle Ware; Gregory M. Sullivan; John Belko; Mary Parker; Paul Rothman; Leonard Chess; Seth Lederman


Antisense & Nucleic Acid Drug Development | 1996

Polydeoxyguanine Motifs in a 12-mer Phosphorothioate Oligodeoxynucleotide Augment Binding to the v3 Loop of HIV-1 gpl20 and Potency of HIV-1 Inhibition Independently of G-Tetrad Formation

Seth Lederman; Gregory M. Sullivan; Lyuba Benimetskaya; Israel Lowy; Kevin Land; Zahangir Khaled; Aileen M. Cleary; Leonid Yakubov; C.A. Stein


Archive | 1997

TRUNCATED CRAFI INHIBITS CD40 SIGNALING

David Baltimore; Genhong Cheng; Zheng-Sheng Ye; Seth Lederman; Aileen M. Cleary


AIDS Research and Human Retroviruses | 1992

Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.

Seth Lederman; John E. Bergmann; Aileen M. Cleary; Michael J. Yellin; Paul J. Fusco; Leonard Chess

Collaboration


Dive into the Aileen M. Cleary's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dale Frank

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge